318 related articles for article (PubMed ID: 36655003)
1. Nuclear Receptor Imaging In Vivo-Clinical and Research Advances.
Parent EE; Fowler AM
J Endocr Soc; 2023 Jan; 7(3):bvac197. PubMed ID: 36655003
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of steroid receptor expression in breast and prostate cancer.
Hospers GA; Helmond FA; de Vries EG; Dierckx RA; de Vries EF
Curr Pharm Des; 2008; 14(28):3020-32. PubMed ID: 18991716
[TBL] [Abstract][Full Text] [Related]
4. Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Kurland BF; Wiggins JR; Coche A; Fontan C; Bouvet Y; Webner P; Divgi C; Linden HM
Oncologist; 2020 Oct; 25(10):835-844. PubMed ID: 32374053
[TBL] [Abstract][Full Text] [Related]
5. Nuclear imaging of hormonal receptor status in breast cancer: a tool for guiding endocrine treatment and drug development.
de Vries EF; Rots MG; Hospers GA
Curr Cancer Drug Targets; 2007 Sep; 7(6):510-9. PubMed ID: 17896918
[TBL] [Abstract][Full Text] [Related]
6. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract][Full Text] [Related]
7. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders.
Yoshinaga K; Chow BJ; dekemp RA; Thorn S; Ruddy TD; Davies RA; DaSilva JN; Beanlands R
Curr Pharm Des; 2005; 11(7):903-32. PubMed ID: 15777243
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Estrogen Receptors Using
Kumar M; Salem K; Jeffery JJ; Fowler AM
Methods Mol Biol; 2022; 2418():129-151. PubMed ID: 35119664
[TBL] [Abstract][Full Text] [Related]
11. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development.
Lever JR
Curr Pharm Des; 2007; 13(1):33-49. PubMed ID: 17266587
[TBL] [Abstract][Full Text] [Related]
12. Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.
Horti AG; Van Laere K
Curr Pharm Des; 2008; 14(31):3363-83. PubMed ID: 19075713
[TBL] [Abstract][Full Text] [Related]
13. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
15. A Review of Molecular Imaging of Glutamate Receptors.
Kim JH; Marton J; Ametamey SM; Cumming P
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081223
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
[TBL] [Abstract][Full Text] [Related]
17. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
18. Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.
Clark AS; McDonald E; Lynch MC; Mankoff D
Oncology (Williston Park); 2014 May; 28(5):424-30. PubMed ID: 25004657
[TBL] [Abstract][Full Text] [Related]
19. The emerging roles of orphan nuclear receptors in prostate cancer.
Wu D; Cheung A; Wang Y; Yu S; Chan FL
Biochim Biophys Acta; 2016 Aug; 1866(1):23-36. PubMed ID: 27264242
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
